Substance Abuse Detection Clinical Trial
Official title:
Optimizing Toxicological Screening in Drug Endangered Children
Background:
- Children who enter the foster care system are all too often exposed to illicit drugs in
the home. Children from these homes, known as drug endangered children, are not
routinely tested for harmful substances. Any short- and long-term physical or
developmental problems they may experience as a result of this exposure often go
undetected and untreated.
- Children who are placed into protective custody are not always screened by physicians or
nurse practitioners. Although drug-endangered children under 18 years of age
automatically receive a urine toxicology screen to determine the types and levels of
illicit drugs in their systems, this procedure has difficulties and limitations that may
affect the quality of the data. Researchers are interested in developing more effective
methods of analyzing the presence or absence of illicit environmental drug exposure in
children.
Objectives:
- To determine the most effective method of identifying long-term illicit stimulant drug
exposure in drug-endangered children.
Eligibility:
- Children under 18 years of age who are being placed into protective custody after having
been found in a home where drugs are manufactured, used, or sold.
Design:
- Researchers will gain verbal consent for the procedure for children who are 7 years of
age or older. Children younger than 7 years of age will not be required to give verbal
consent for sample collection.
- Researchers will collect standard urine samples for toxicological screening. Part of the
sample will be sent to the National Institute on Drug Abuse for evaluation; the rest
will remain with the local authority.
- In addition to this standard procedure, researchers will collect a hair sample by
cutting a small amount of hair from the crown of the head as close to the root as
possible (and not pulling any hair out of the child's head).
- Researchers will also use an oral swab to collect a saliva sample from the inside cheek
of each child.
- No clinical care will be provided under this protocol....
This is a single-center, investigator-initiated study to determine the best method for analyzing the presence or absence of illicit environmental drug exposure in children placed into protective custody in Sacramento County. In collaboration with the National Institutes of Health (NIH), National Institute of Drug Abuse (NIDA) we will use diagnostic procedures to determine the presence of illicit drugs in the following three samples: (1) hair; (2) oral swab; and (3) urine. These samples will be sent to a designated NIH lab site where 100 de-identified samples will be analyzed for methamphetamine, amphetamine, Ecstasy (MDMA), and MDEA. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01124591 -
Brief Intervention for Drug Misuse in the Emergency Department
|
Phase 2 | |
| Completed |
NCT01545778 -
Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)
|
N/A |